Fractyl Health Inc.
Nasdaq GUTS · Burlington, MA
Works in Immunology · Metabolic & endocrine
Fractyl Health Inc. is a clinical trial sponsor based in Burlington, MA, listed as Nasdaq GUTS. It has 1 active clinical trial with 315 planned participants, in Immunology and Metabolic & endocrine. Since 2021 it has completed 4 trials and stopped 2 early.
Trial track record · since 2021
Financials · Nasdaq GUTS
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Fractyl Health Inc
Fractyl Health Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 315 planned participants, in Immunology, Metabolic & endocrine. Since 2021 it has completed 4 trials and stopped 2 early.
Fractyl Health Inc is based in Burlington, MA and is listed as Nasdaq GUTS. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Fractyl Health Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-03-03.
Approve Suite is not affiliated with Fractyl Health Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.